Treatment Outcome and Metacognitive Change in CBT and GET for Chronic Fatigue Syndrome.
Fernie, Bruce A, Murphy, Gabrielle, Wells, Adrian et al. · Behavioural and cognitive psychotherapy · 2016 · DOI
Quick Summary
This study tested whether two common treatments for ME/CFS—cognitive behavioral therapy (CBT) and graded exercise therapy (GET)—work equally well in real-world clinical settings. Researchers found that both treatments reduced fatigue, anxiety, and depression, and improved physical functioning similarly. They also discovered that changes in how patients think about their symptoms (measured by a questionnaire) were linked to improvements in fatigue, regardless of which treatment they received.
Why It Matters
Understanding whether CBT and GET perform similarly in clinical practice versus controlled trials is crucial for patients and clinicians making treatment decisions. This study provides real-world evidence about treatment effectiveness and identifies metacognition as a potential mechanism of change, which could inform how treatments are refined and delivered.
Observed Findings
Both CBT and GET produced similar reductions in fatigue severity at post-treatment and follow-up
Both treatments similarly reduced anxiety and depression scores
Physical functioning improved comparably in both treatment groups
Changes in metacognitive beliefs (worry about thinking, cognitive confidence, and thought control) independently predicted fatigue improvement across both treatments
Real-world treatment outcomes were similar to or poorer than those reported in the PACE trial
Inferred Conclusions
CBT and GET are equally effective for reducing fatigue and associated symptoms in routine clinical practice
Metacognitive change may be a common mechanism underlying treatment response across different treatment modalities
The discrepancy between trial and routine practice outcomes suggests challenges in translating research protocols to clinical settings
Current CBT and GET protocols based on PACE trial methods may have limited real-world effectiveness compared to controlled research conditions
Remaining Questions
Why do treatments show poorer outcomes in routine practice compared to the PACE trial, and what factors in real-world settings explain this difference?
What This Study Does Not Prove
This observational study cannot establish causation—the association between metacognitive changes and fatigue improvement does not prove that changing thinking patterns causes fatigue reduction. The study also does not explain why real-world outcomes were poorer than trial results, nor does it determine which treatment is objectively superior for specific patient subgroups. It does not address whether GET might cause harm in some patients, a concern raised by some ME/CFS advocates.
Tags
Symptom:Cognitive DysfunctionFatigue
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsExploratory Only